TRI MIX 40/30/2 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/2mg/mL, Rx only, 5 mL Glass/Multi...

FDA Recall #D-0747-2017 — Class II — April 18, 2017

Recall #D-0747-2017 Date: April 18, 2017 Classification: Class II Status: Terminated

Product Description

TRI MIX 40/30/2 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/2mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

Reason for Recall

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Recalling Firm

Key Pharmacy and Compounding Center — Federal Way, WA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2 vials

Distribution

Distributed nationwide in U.S.A., Australia and Canada.

Code Information

Lot # t02-02-2017@93, Exp 8/2/2017

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated